Detailed Narrative
2030 Strategy Launch and Operational Resilience
Colgate launched its new 2030 strategy, building on the 2025 strategy which added $5 billion in sales. The new strategy focuses on leveraging strong global brands, accelerating science-based innovation, enhancing omnichannel demand generation, and investing in digital, data, analytics, and AI. This is supported by a strategic growth and productivity program (SGPP) designed to unlock organizational changes and funding for long-term growth and margin expansion.
Q4 Momentum and Category Stabilization
The company exited 2025 with improved momentum, achieving organic sales growth in all four categories in Q4 and sequential improvement in organic sales growth in every division except North America. Modest volume growth was recorded in Q4, excluding the Prime100 acquisition and private label exit. While category growth rates have stabilized, they remain low, in the 1.5% to 2.5% range, posing challenges for the competitive environment.
North America Performance and Strategic Focus
North America experienced a tough Q4, although it showed improvement from Q3, with continued category sluggishness, particularly in Personal Care and Home Care. This was attributed to consumer uncertainty🌐 and pantry destocking. The company plans to address these challenges with a stronger innovation pipeline for 2026, focused revenue growth management strategies, and a dual approach of driving premium innovation while also competing effectively in value segments.
Strong Emerging Markets Performance
Emerging markets broadly delivered strong organic growth of approximately 4.5% in Q4, demonstrating a good balance between price and volume. Latin America, especially Mexico and Brazil, showed very strong performance with high single-digit growth. Asia also improved sequentially, with India returning to growth and Hawley & Hazel showing progress driven by successful new product entries in e-commerce.
Hill's Pet Nutrition Continues Strong Growth
Hill's delivered a strong quarter despite a soft overall pet category backdrop, achieving 2% underlying volume growth when excluding the impact of private label. Therapeutic products, particularly the Prescription Diet business, were a significant growth driver, contributing to improved market shares and positive mix and operating margins. The Tonganoxie plant's increased flexibility is also supporting greater wet product delivery globally.
FX Impact and Flexible Management Approach
Foreign exchange is anticipated to provide a low single-digit benefit to revenue in 2026, primarily in the first half. This FX benefit will be utilized as part of the company's flexible business model, allowing for reinvestment back into the business and contributing to the bottom line. Management emphasizes that experienced teams will navigate currency volatility🌐 through revenue growth management and pricing strategies, rather than solely relying on FX for planning.
Organizational Evolution for Omni-Demand Generation
The Strategic Growth and Productivity Program (SGPP) is central to evolving the organizational structure to meet changing consumer environments. This involves de-siloing e-commerce and brick-and-mortar operations to create a holistic 'omni demand generation' commercial organization. The goal is to drive faster decision-making, optimize asset utilization, and enable dynamic, personalized messaging to consumers across all channels.